These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1979942)

  • 21. [Duty militaries' consumption of psychotropic drugs in 2005].
    Desjeux G; Aspar AM; Colonna-d'Istria E; Raude D; Birioukoff M; Balaire C; Codaccioni A; Thevenin-Garron V
    Encephale; 2009 Jun; 35(3):249-55. PubMed ID: 19540411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of patients on risperidone depot.
    Nesvåg R; Tanum L
    Nord J Psychiatry; 2005; 59(1):51-5. PubMed ID: 16195099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroleptics in psychogeriatrics. A proposal for a more rational prescription policy].
    Willekens-Bogaers MA; Vollaard EJ
    Tijdschr Gerontol Geriatr; 1985 Oct; 16(5):179-89. PubMed ID: 2867625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impace of depot neuroleptics on psychiatry.
    Corbett L
    Minn Med; 1979 Feb; 62(2):97-100. PubMed ID: 34788
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prescribing practice of psychotropic drugs in a psychiatric university clinic].
    Ambühl B; Würmle O; Michel K
    Psychiatr Prax; 1993 Mar; 20(2):70-3. PubMed ID: 8103601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany.
    Haring C; Tegeler J; Lehmann E; Ptock WD
    Acta Psychiatr Belg; 1981; 81(2):189-202. PubMed ID: 6117189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic depot medication and attitudes of community psychiatric nurses.
    Patel MX; DE Zoysa N; Baker D; David AS
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):237-44. PubMed ID: 15788043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The study of the impact of the consensus conference "Strategies for long-term therapy of patients with schizophrenia"].
    Glikman J; Pazart L; Casadebaig F; Philippe A; Lachaux B; Kovess V; Cochet Faurisson C; Terra JL; Durocher A
    Encephale; 1999; 25(6):558-68. PubMed ID: 10668598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot neuroleptics : a Scandinavian view.
    Dencker SJ
    Acta Psychiatr Belg; 1981; 81(2):115-20. PubMed ID: 6117182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Schizophrenia: prophylaxis prevents recurrence. Low dose depot neuroleptics--an exit from the "revolving door" psychiatry].
    Fortschr Med Suppl; 1993; 147():1-15. PubMed ID: 9260317
    [No Abstract]   [Full Text] [Related]  

  • 37. The underutilization of depot neuroleptic therapy.
    Balon R
    J Clin Psychiatry; 1994 Jan; 55(1):39. PubMed ID: 7904995
    [No Abstract]   [Full Text] [Related]  

  • 38. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

  • 39. Associated factors with antipsychotic use in assisted living facilities: a cross-sectional study of 4367 residents.
    Larrayadieu A; Abellan van Kan G; Piau A; Soto Martin M; Nourhashemi F; Rolland Y; Vellas B
    Age Ageing; 2011 May; 40(3):368-75. PubMed ID: 21429950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.
    Desai NM; Huq Z; Martin SD; McDonald G
    Adv Ther; 1999; 16(2):78-88. PubMed ID: 10539380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.